Q2 2021

Filed Aug 23, 2021 · 10-Q · 54 days after period end · 0001096906-21-002137

Q2 2021 · 10-Q

Revenue

$14.88K

— vs Q2 2020

Net Income

-$3.83M

N/M vs Q2 2020

EPS Diluted

-$0.03

— vs Q2 2020

Gross Profit$14,875—

Operating Income

Same quarter

Metric	Q2 2021	Q2 2020	Q2 2019	Q2 2018
Revenue	$14.88K	$0.00	—	$8.17K
Net Income	-$3.83M	-$79.39K	-$1.81M	-$1.68M
EPS Diluted	-$0.03	$0.00	-$0.03	-$0.03

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Axim Biotechnologies, Inc. · CIK 1514946 · Engraved from SEC EDGAR